CSR and Sustainability Forum
A roundup of developments on corporate social responsibility from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
US Outlines Plan for IP Protection and Securing the Pharmaceutical Supply Chain
The US government outlines its strategy against counterfeiting and intellectual-property infringement, including ways to better secure the pharmaceutical supply chain.
A Green Assessment Tool for Formulated Products
Led by sustainability efforts by Walmart, a new tool emerges for quickly evaluating the environmental and human-health profile of formulated products.
Patient Capital, a New Option in Social Impact Investing
Acumen Fund, a nonprofit venture-capital fund, uses patient capital to build economically sustainable businesses involved in poverty alleviation.
EU Debt Crisis Adds Uncertainty
The sovereign debt crisis in the EU could greatly change the landscape for contract services.
